The aim is to evaluate the efficacy of a genipin-crosslinked CeO2-incorporated Janus patch in treating oral ulcers.
Developed a genipin-crosslinked CeO2 Janus patch for localized treatment.
Assessed its therapeutic effectiveness in oral ulcer models.
The Janus patch significantly alleviated ulcer symptoms compared to conventional treatments.
Provided sustained localized therapy for enhanced healing.
Abstract
The genipin-crosslinked CeO 2 -incorporated Janus patch provides a robust and localized therapeutic strategy for oral ulcers, offering a clinically relevant platform.